An antibody can be associated with a disease without establishing that the person in front of you has it. A negative result can also be less reassuring than it appears when the wrong antibody class has been measured or the clinical pattern remains persuasive.
This immunology quiz begins with four mechanism matches, then moves into five original fictional cases. The questions ask what a result means in context, not simply which disease name is most often printed beside it.
Keep your initial answer separate from the explanation. For each case, write one sentence stating what the evidence supports and another stating what it does not establish. That distinction is the main learning task.
Round 1: connect the component to its role
Match each component with the most appropriate description.
A. C3b
B. The C5b-9 membrane attack complex
C. A cytotoxic CD8 T lymphocyte
D. A plasma cell
1. A differentiated B-lineage cell specialised for antibody secretion.
2. A complement product that can coat a target and support its recognition by phagocytes.
3. A terminal complement assembly capable of forming membrane pores.
4. A lymphocyte that can recognise relevant peptide presented by MHC class I and kill the target cell.
For an additional challenge, explain why components A and B belong to the same broader system without performing the same function.
Round 2: interpret the clinical association
1. A positive ANA in a thin clinical context
A 37-year-old has persistent tiredness. An antinuclear antibody test, requested before a focused autoimmune assessment, is reported as positive at a titre of 1:80. The history supplied contains no inflammatory joint symptoms, characteristic rash, oral ulceration or other specific connective-tissue-disease findings. The initial blood count and renal assessment are unremarkable.
Which conclusion is best supported?
A. The ANA result independently establishes systemic lupus erythematosus.
B. The result needs interpretation alongside the clinical assessment; it does not establish lupus by itself.
C. The result establishes that the tiredness cannot have an autoimmune cause.
Follow-up question: what clinical question should the clinician clarify before treating a broader antibody panel as an automatic next step?
2. Negative antibodies, persistent synovitis
A 49-year-old has several months of prolonged morning stiffness and persistent swelling of several MCP and PIP joints. Examination identifies synovitis. Rheumatoid factor and anti-CCP antibodies are negative.
Which interpretation is more appropriate?
A. The negative antibodies exclude rheumatoid arthritis and make further assessment of the synovitis unnecessary.
B. Seronegative rheumatoid arthritis remains possible; the clinical inflammatory pattern still requires assessment.
Follow-up question: which observation in this case is more important than treating the blood results as a binary permission to consider inflammatory arthritis?
3. The negative test depends on an absent antibody class
A 30-year-old with chronic loose stools and otherwise unexplained iron deficiency is eating a gluten-containing diet. Tissue transglutaminase IgA is negative, but total IgA is below the assay's detection limit.
Which is the stronger interpretation?
A. The negative tTG-IgA reliably excludes coeliac disease.
B. The negative IgA-based result is insufficient in this context; appropriate IgG-based testing and the wider diagnostic pathway need consideration.
Follow-up question: why does checking total IgA answer a different question from simply repeating the same tTG-IgA measurement?
4. One antiphospholipid result after a thrombosis
A patient is undergoing specialist investigation after an unprovoked venous thrombosis. A lupus anticoagulant result is positive. Assume the laboratory has assessed the sample as interpretable, without a recognised interfering anticoagulant effect. No earlier antiphospholipid results are available.
Which statement is best supported?
A. This single result completes the assessment of antiphospholipid syndrome.
B. The result is relevant, but its persistence and the complete clinical and laboratory picture still need assessment.
Follow-up question: what minimum interval is generally used when repeating a positive antiphospholipid test to assess persistence?
The question concerns interpretation. Necessary thrombosis treatment should not be stopped or delayed to make a teaching exercise or laboratory pathway simpler.
5. Recurrent infection suggests a functional pathway
A young adult has experienced recurrent invasive Neisseria infections. Immunology assessment raises the possibility of a complement defect, despite no simple abnormality in the initial measurement of one individual complement protein.
Which part of the system is particularly relevant?
A. The terminal complement pathway involving C5-C9.
B. Only IgE-mediated mast-cell activation.
C. A guarantee that all complement functions are intact because one concentration is within range.
Follow-up question: why might a functional pathway test provide information that a single protein concentration cannot?
Answer key: mechanisms
1-D and 4-C: antibody secretion and targeted cellular killing
A plasma cell is specialised for antibody secretion. A cytotoxic CD8 T cell can recognise a relevant peptide-MHC class I complex and act against the presenting target.
The distinction separates a secreted immune product from the activity of an effector cell. It does not imply that these arms of immunity never interact.
The relationships are described in OpenStax's chapters on B cells and antibodies and T-cell functions.
2-A and 3-B: recognition and membrane injury are different functions
C3b can support opsonisation: coating a target in a way that helps phagocytes recognise it. The membrane attack complex is a terminal assembly with a pore-forming role.
Both belong to complement, but "complement kills microbes" is too broad to explain the particular contribution of each. OpenStax's innate-immunity chapter sets out these distinct functions.
That same move from a broad category to a precise relationship is central to clinical connections, where sixteen concepts must be organised into four groups.
Answer key: clinical cases
1. B: a positive ANA is a finding, not a complete diagnosis
The American College of Rheumatology's ANA explanation makes clear that positive results can occur without an autoimmune disease and need interpretation in relation to symptoms, examination and other findings.
The next intellectual task is to identify whether there is a plausible connective-tissue-disease pattern to investigate. A low-information presentation should not be transformed into a confirmed diagnosis by the presence of one positive test.
Equally, the case does not justify saying that an autoimmune explanation is impossible. The appropriate conclusion preserves uncertainty without giving the result more authority than it has.
2. B: the persistent synovitis remains important
Negative rheumatoid factor and anti-CCP results do not exclude every case of rheumatoid arthritis. ARUP Consult's rheumatoid-arthritis guidance discusses seronegative disease and the role of clinical assessment.
The important observation here is persistent synovitis in a relevant pattern. That warrants assessment of inflammatory arthritis and its alternatives rather than dismissal because two associated markers were absent.
This is not a reason to diagnose rheumatoid arthritis from the vignette alone. It is a reason not to make positive serology a mandatory prerequisite for taking the examination finding seriously.
3. B: test selection depends on the patient's immunoglobulin context
An IgA-based test is difficult to use as an exclusion when the patient cannot produce a measurable amount of the relevant immunoglobulin class.
ARUP Consult's coeliac-disease guidance describes assessing total IgA and using appropriate IgG-based tests, such as tTG-IgG or DGP-IgG, when IgA deficiency is present.
The patient is still eating gluten, which preserves another important part of the testing context. The result and symptoms should be considered within the full diagnostic pathway rather than treating one replacement blood test as universally conclusive.
The mistake to avoid is repeating a technically available test without addressing why its interpretation was limited in the first place.
4. B: persistence matters, but classification is not the whole clinical decision
A positive antiphospholipid result is generally repeated at least twelve weeks later to assess persistent positivity. ARUP Consult's APS guidance also distinguishes clinical diagnosis from classification criteria developed for research.
The relevant testing includes lupus anticoagulant, anticardiolipin and anti-beta-2 glycoprotein I antibodies. A single interpretable positive result provides information, but not the complete clinical and laboratory account.
Real testing can be affected by an acute thrombotic episode and anticoagulants. Timing and methods therefore need specialist and laboratory input. The simplified assumption in the question is not an instruction to interrupt necessary anticoagulation.
5. A: consider the terminal complement pathway
Recurrent invasive Neisseria infection is an important association with terminal complement defects. ARUP Consult's complement-testing guidance describes pathway testing and subsequent investigation of individual components.
A protein can be present in a measurable quantity without functioning normally. Conversely, an abnormal pathway test can have several explanations; it does not automatically establish an inherited deficiency.
The task is to connect the infection pattern with a plausible defence mechanism, then determine which testing can assess that mechanism. It is not to infer the patient's genetic diagnosis from the organism name alone.
Three different reasons a test can mislead
These cases illustrate different interpretive problems rather than one general message that antibody tests are unreliable.
The ANA question concerns the meaning of a positive result when the clinical basis is weak. The synovitis question concerns the limits of a negative disease-associated marker. The coeliac question concerns whether the chosen assay matches the patient's ability to produce that antibody class.
The APS example adds time: an isolated result and a persistent finding are different observations. The complement example adds function: concentration and biological performance are not interchangeable.
When reviewing your answers, name the specific problem. "I should be cautious with tests" is less useful than "I treated a negative IgA result as an exclusion without checking whether IgA was present."
A small discussion exercise for colleagues
Choose the coeliac and rheumatoid-arthritis cases. Ask two people to explain why the negative result is insufficient in each, without using the same explanation for both.
Then reverse the challenge. Ask what new information would make their preferred interpretation less persuasive. This keeps the discussion open to alternatives rather than rewarding a memorised association.
These are suggested teaching prompts, not an automated iatroX workflow or a validated assessment. No patient details are needed to use them.
Continue with the relationship you found difficult
A useful follow-up might be revisiting complement functions, clarifying assay selection or understanding how clinical findings influence the interpretation of serology.
Choose one of those tasks rather than assuming a missed question means that all immunology needs revising.
The daily clinical connections game offers another association exercise with group explanations and a separate optional application question. Its mixed clinical-science format means today's edition is not guaranteed to contain immunology or autoantibodies.
Frequently asked questions
Does a positive autoantibody result establish an autoimmune disease?
Not by itself. Its meaning depends on the antibody, assay, clinical presentation and other evidence. The result should answer a defined clinical question rather than replace one.
Can autoimmune disease be present when a commonly associated antibody is negative?
Yes, depending on the condition and test. The synovitis example shows why a negative associated marker should not automatically overrule a persuasive clinical finding.
Is this quiz a guide to ordering every available antibody test?
No. It is an exercise in mechanisms and interpretation. Test selection should follow the clinical question, appropriate guidance and relevant specialist or laboratory advice.
Find a fresh set of relationships in today's clinical connections puzzle